Detection of Small Fiber Neuropathy Using Skin Properties
1 other identifier
observational
400
1 country
1
Brief Summary
Small fiber neuropathy affects millions of peoples worldwide. The neuropathy is causing disabling burning pain and dysautonomia such as dizziness with standing, brain fog, fatigue, constipation, too much or too little sweating. The detection of nerve damage is complicated and not widely available; it requires either skin biopsy or specialized equipment and training. This project utilizes the mathematical processing of skin pictures for the purpose to extract the statistical features related to loss of small fibers. This approach can improve the availability of diagnosis of small fiber neuropathy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 15, 2021
CompletedFirst Posted
Study publicly available on registry
February 18, 2021
CompletedStudy Start
First participant enrolled
July 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
February 6, 2025
February 1, 2025
5.6 years
February 15, 2021
February 4, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Diagnostic accuracy of image processing
The diagnostic accuracy of image processing will be evaluated by using the skin biopsy as a reference.
2 years
Interventions
Image processing will be used to extract skin features that correlate with loss of small skin fibers.
Eligibility Criteria
Patients with small fiber neuropathy
You may qualify if:
- Patients with age 18 year or older
- Patients that sign the informed consent form to participate in this study
- Patients completed the autonomic testing with skin biopsies
You may not qualify if:
- Patients with significant hairs at the legs that will cover the skin
- Any dermatological disorder that can affect the skin composition
- The use of skin lotion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Brigham and Women's Faulkner Hospital
Boston, Massachusetts, 02130, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Autonomic Laboratory
Study Record Dates
First Submitted
February 15, 2021
First Posted
February 18, 2021
Study Start
July 1, 2021
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
February 1, 2027
Last Updated
February 6, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share